Section 3.1 Intellectual Property Ownership. Except as expressly set forth herein, as between the Parties, each Party is and shall remain the owner of all intellectual property that it owns or controls as of the Effective Date or that it develops or acquires thereafter.
4.1 Licenses and Intellectual Property Ownership. 4.1 Marketing Materials License. Subject to the terms and conditions of this Agreement, NantOmics hereby grants to NantHealth a non-exclusive, non-transferable (except in accordance with Section16.4), sublicensable (solely to NantHealth Subsidiaries), worldwide right and license to use, reproduce and distribute any artwork or other marketing materials provided by NantOmics for inclusion in the marketing materials used by NantHealth for the Omics Services hereunder, provided that NantHealth must receive the prior approval of such marketing materials prior to distributing any such marketing materials (which approval will not to be unreasonably withheld).
a.Custom Device Development and Intellectual Property Ownership. Any intellectual property generated via the specific development of a specific custom product on behalf of a specific customer or by the Distributor will be shared between the company, the costumer and the distributor as follows 50% for the company developing, 25% for the distributor and 25% for the customer (surgeon).
13.1. Intellectual Property Ownership. As between the Parties, each Party shall retain all rights, title and ownership of its own Background Intellectual Property.
2.8.Statement of Via’s Intellectual Property Ownership. Via shall own all right, title and interest, including without limitation all intellectual property rights, in and to the Via Administration System, ViaSecure, the Via trademarks, trade names, trade dress, service marks and the associated names and logos used by Via from time to time.